Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

This publication has 79 references indexed in Scilit:

• Brain-Derived Neurotrophic Factor-Mediated Protection of Striatal Neurons in an Excitotoxic Rat Model of Huntington's Disease, as Demonstrated by Adenoviral Gene Transfer
  Human Gene Therapy, 1999
• A triploblast origin for Myxozoa?
  Nature, 1998
• Chapter 35 Prospectives for cell and gene therapy in Huntington's disease
  Published by Elsevier ,1998
• Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease
  Neuroscience, 1997
• Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease.
  Proceedings of the National Academy of Sciences, 1996
• Gene Therapy for Amyotrophic Lateral Sclerosis (ALS) Using a Polymer Encapsulated Xenogenic Cell Line Engineered to Secrete hCNTF. Lausanne University Medical School, Lausanne, Switzerland
  Human Gene Therapy, 1996
• Time course of ciliary neurotrophic factor mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum
  Journal of Neuroscience Research, 1995
• Characterization of a Pathway for Ciliary Neurotrophic Factor Signaling to the Nucleus
  Science, 1993
• Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
  Annals of Neurology, 1992
• Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
  Nature, 1986